logo
  

IDEXX Laboratories Inc. (IDXX) Rose To A 3-Month High After Q3 Profit Beat

IDEXX Laboratories Inc. (IDXX) reported third quarter adjusted EPS of $1.05 Friday morning, which topped the consensus estimate of $0.90. The company also increased its full year EPS forecast to between $3.85 and $3.90, from previous expectations of $3.79 to $3.86. The consensus estimate is for EPS of $3.82.

IDEXX Laboratories gapped open sharply higher Friday and rose during the first hour of trade, before settling into a range. The stock closed up by 8.85 at $135.20 on the highest volume of the year. IDEXX Laboratories closed challenging the highs of the year, trading at a 3-month high.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.

A busy week for economics saw the release of first quarter growth figures for the U.S. economy and the interest rate decision in Japan. Read our stories to find out why the GDP data damped market sentiment in the U.S. and what were the signals given out by the Bank of Japan. Other news this week included new home sales data and jobless claims figures from the U.S., and the latest purchasing managers' survey results for the Eurozone.

View More Videos
Follow RTT